FEATURED

COVID 19 Articles

Trending COVID 19 News

Vaxart Q2 Earnings Call Highlights

Vaxart reported favorable 12-month safety data from its Phase II-B COVID-19 vaccine trial’s 400-person sentinel cohort, with top-line data from the larger 5,000-participant study expected in the first half of 2027.

read more